Next GEN Pharma SRL
The score of Next GEN Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +69 % Total assets +1 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Next GEN Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Aug 2026
- Year ended 31 Dec 2024filed on 13 Jul 2025
- Year ended 31 Dec 2023filed on 18 Jul 2024
Next GEN Pharma's financial analysis
- Solvency51.5%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Next GEN Pharma
Next GEN Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0794.344.975
- VAT number
- BE0794344975
- Peppol
- Registered · 0208:0794344975 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Dec 2022
- Registered office
- 9620 Zottegem
- Latest accounts
- 2025 · filed on 07 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
Next GEN Pharma (SRL) has been based in Zottegem since 2022, active in: activities of holding companies. For 2025, it reports a net profit of 611,794 € and equity of €3.19m; its revenue is not published. Its solvency stands at 51.5%, below the median of its sector (55.6%).
Companies similar to Next GEN Pharma
Companies in the same business, of comparable size and area, outside its group.
- PiliPili Anvest Activities of holding companies Mechelen · balance sheet €5.95m
- Portofino Beheer Activities of holding companies Antwerp · balance sheet €5.91m
- Tifre Group Activities of holding companies Knokke-Heist · balance sheet €6.47m
- Cerizo Activities of holding companies Ostend · balance sheet €6.51m
- Nobis Holding Activities of holding companies Herk-de-Stad · balance sheet €6.65m
- Crescent Ventures Activities of holding companies Leuven · balance sheet €6.66m
- Tiebo Activities of holding companies Oostkamp · balance sheet €6.70m
- HSI Activities of holding companies Antwerp · balance sheet €6.72m
Frequently asked questions about Next GEN Pharma
What is the revenue of Next GEN Pharma?
Next GEN Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Next GEN Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0794344975 for Next GEN Pharma, if the company is VAT-registered. Its company number (CBE) is 0794.344.975.
Where is the registered office of Next GEN Pharma?
According to the CBE register, the registered office of Next GEN Pharma is in 9620 Zottegem.
What is the equity of Next GEN Pharma?
At the close of the 2025 financial year, the equity of Next GEN Pharma amounts to 3,185,994 €, a solvency of 51.5% of total assets.
Who manages Next GEN Pharma?
The register lists 1 active mandates at Next GEN Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Next GEN Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →